New FDA Team Seeks To Spur Antibiotics Innovation
The U.S. Food and Drug Administration on Monday announced the creation of a new task force to look at incentives for drug companies to develop new antibiotics to battle increasingly drug-resistant...To view the full article, register now.
Already a subscriber? Click here to view full article